NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Whole-Body Vibration in Parkinson Disease

Active Not RecruitingNA

Sponsor: Izmir Bakircay University

Conditions: Parkinson's Disease, Balance, Gait, Cognitive Function, Dual-Task Performance

Interventions: Functional Exercise Based Physiotherapy, Low-Frequency Whole-Body Vibration Therapy, Medium-Frequency Whole-Body Vibration Therapy

Countries: Turkey (Türkiye)

The aim of this study is to evaluate the effects of different frequencies of Whole Body Vibration (WBV) application on balance, gait, cognitive functions, and dual-task performance in patients with Parkinson's disease. Study Hypotheses: H0.1 - There is no effect of different frequencies of WBV application on balance performance in patients with Parkinson's disease. H1.1 - There is an effect of different frequencies of WBV application on balance performance in patients with Parkinson's disease. H0.2 - There is no effect of different frequencies of WBV application on gait performance in patients with Parkinson's disease. H1.2 - There is an effect of different frequencies of WBV application on gait performance in patients with Parkinson's disease. H0.3 - There is no effect of different frequencies of WBV application on cognitive functions in patients with Parkinson's disease. H1.3 - There is an effect of different frequencies of WBV application on cognitive functions in patients with Parkinson's disease. H0.4 - There is no effect of different frequencies of WBV application on dual-task performance in patients with Parkinson's disease. H1.4 - There is an effect of different frequencies of WBV application on dual-task performance in patients with Parkinson's disease. H0.5 - There is no effect of different frequencies of WBV application on reaction time in patients with Parkinson's disease. H1.5 - There is an effect of different frequencies of WBV application on reaction time in patients with Parkinson's disease. H0.6 - There is no significant difference between medium-frequency and low-frequency WBV in terms of balance performance in patients with Parkinson's disease. H1.6 - There is a significant difference between medium-frequency and low-frequency WBV in terms of balance performance in patients with Parkinson's disease. H0.7 - There is no significant difference between medium-frequency and low-frequency WBV in terms of gait performance in patients with Parkinson's disease. H1.7 - There is a significant difference between medium-frequency and low-frequency WBV in terms of gait performance in patients with Parkinson's disease. H0.8 - There is no significant difference between medium-frequency and low-frequency WBV in terms of cognitive functions in patients with Parkinson's disease. H1.8 - There is a significant difference between medium-frequency and low-frequency WBV in terms of cognitive functions in patients with Parkinson's disease. H0.9 - There is no significant difference between medium-frequency and low-frequency WBV in terms of dual-task performance in patients with Parkinson's disease. H1.9 - There is a significant difference between medium-frequency and low-frequency WBV in terms of dual-task performance in patients with Parkinson's disease. H0.10 - There is no significant difference between medium-frequency and low-frequency WBV in terms of reaction time in patients with Parkinson's disease. H1.10 - There is a significant difference between medium-frequency and low-frequency WBV in terms of reaction time in patients with Parkinson's disease.

Eligibility overview

Sex: ALL

Age: 30 Years to 80 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria

* Individuals aged 30-80 years with a clinical diagnosis of Parkinson's disease. Hoehn and Yahr stages 1-3.
* Stable medical treatment (no changes in medication for the past 4 weeks).
* Willingness to participate and provision of written informed consent.
* Score of 24 or higher on the Standardized Mini Mental State Examination (SMMSE).

Exclusion Criteria

* Advanced stage Parkinson's disease (Hoehn and Yahr stage \>3) or presence of severe motor complications.
* History of surgical interventions or other neurological/vestibular disorders that may affect balance and gait (E.G., stroke, epilepsy, peripheral neuropathy).
* Presence of severe cardiovascular or respiratory conditions that may affect stability (E.G., heart failure, uncontrolled hypertension, advanced COPD).
* Conditions contraindicating whole-body vibration (WBV) application (E.G., severe osteoporosis, active thrombosis).
* Psychiatric disorders or major depression that may interfere with treatment participation.
* Significant communication or language impairments affecting participation.

Withdrawal Criteria

* Voluntary withdrawal from the study.
* Development of health problems during the intervention that prevent completion of the study (E.G., unexpected acute illness or temporary medical condition).
* Changes in medication or medical status during the study that may affect participation or performance.
* Non-adherence to the protocol (attendance rate below 80% of sessions).

Locations (1)

Izmir, Turkey (Türkiye)